WallStreetZenWallStreetZen

NASDAQ: SNDX
Syndax Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Syndax Pharmaceuticals revenue was $252.25M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was $72.8M, up 12.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SNDX annual revenue was $172.4M, with 627.8% growth year-over-year.

SNDX past revenue growth

How has SNDX's revenue growth performed historically?

Company
222.65%
Industry
273.72%
Market
34.43%
SNDX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SNDX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SNDX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SNDX revenue history

Current Revenue
$252.3M
Current Earnings
-$220.8M
Current Profit Margin
-87.5%

Be the first to know when SNDX announces revenue.

SNDX Revenue History By Year

SNDX Yearly RevenueSNDX RevenueSNDX ChangeSNDX Revenue Growth
2025-12-31$172.35M$148.67M+627.84%
2024-12-31$23.68MN/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00-$139.71M-100.00%
2021-12-31$139.71M$138.19M+9,109.56%
2020-12-31$1.52M$0.000.00%
2019-12-31$1.52M$0.000.00%
2018-12-31$1.52M-$591.00k-28.04%
2017-12-31$2.11M$888.00k+72.79%
2016-12-31$1.22M$593.00k+94.58%
2015-12-31$627.00kN/AN/A
2014-12-31$0.00N/AN/A

1 of 1

Syndax Pharmaceuticals Revenue FAQ

What was SNDX's revenue last quarter?

On Aug 4, 2026, Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q2 2026 revenue of $72.79 million up 91.76% year over year. In the same quarter last year, Syndax Pharmaceuticals's revenue was $37.96 million.

What was Syndax Pharmaceuticals's revenue in 2025?

Syndax Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2025 was $172.35 million, a 627.84% increase year over year.

How much does Syndax Pharmaceuticals make in a day?

Based on Syndax Pharmaceuticals annual revenue for the past five years, SNDX makes an average of $183,967.67 per day.

What was Syndax Pharmaceuticals's annual revenue growth in the past year?

As of Q3 2026, Syndax Pharmaceuticals's revenue has grown 222.65% year over year. This is 51.07 percentage points lower than the US Biotechnology industry revenue growth rate of 273.72%. Syndax Pharmaceuticals's revenue in the past year totaled $252.25 million.

How much does Syndax Pharmaceuticals make in a year?

Syndax Pharmaceuticals's revenue by year for the past five years is:
  • Syndax Pharmaceuticals's revenue for the twelve months ending Dec 31, 2025 was $172.35 million, a 627.84% increase year over year.
  • Syndax Pharmaceuticals's annual revenue for Dec 31, 2024 was $23.68 million, a Infinity% increase from 2023.
  • Syndax Pharmaceuticals's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
  • Syndax Pharmaceuticals's annual revenue for 2022 was $0.00, a 100% decrease from 2021.
  • Syndax Pharmaceuticals's annual revenue for 2021 was $139.71 million, a 9,109.56% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.